학술논문

Change in Splenic Volume as a Surrogate Marker for Immunotherapy Response in Patients with Advanced Urothelial and Renal Cell Carcinoma—Evaluation of a Novel Approach of Fully Automated Artificial Intelligence Based Splenic Segmentation.
Document Type
Article
Source
Biomedicines; Sep2023, Vol. 11 Issue 9, p2482, 12p
Subject
RENAL cell carcinoma
TRANSITIONAL cell carcinoma
BIOMARKERS
ARTIFICIAL intelligence
PROGNOSIS
Language
ISSN
22279059
Abstract
Copyright of Biomedicines is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)